Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on January 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cooper Companies stock on December 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Schneider Electric S.E. (OTCMKTS:SBGSF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 12/30/2025.
• Purchased $50,001 – $100,000 in shares of Campbell’s (NASDAQ:CPB) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 12/26/2025.
• Sold $1,001 – $15,000 in shares of Bloom Energy (NYSE:BE) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Coinbase Global (NASDAQ:COIN) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 12/24/2025.

Cooper Companies Stock Down 0.0%

Shares of NASDAQ COO traded down $0.01 during trading on Wednesday, hitting $81.69. 2,695,506 shares of the company traded hands, compared to its average volume of 2,051,301. The firm has a market capitalization of $16.01 billion, a price-to-earnings ratio of 43.45, a P/E/G ratio of 2.33 and a beta of 1.03. The business’s fifty day moving average is $78.71 and its 200 day moving average is $73.58. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $100.24.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has authorized a stock repurchase plan on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the medical device company to buy up to 15.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

COO has been the subject of a number of recent analyst reports. Mizuho set a $100.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Friday, December 5th. Barclays reiterated an “overweight” rating and issued a $91.00 price objective on shares of Cooper Companies in a report on Monday, December 8th. Stifel Nicolaus set a $95.00 price target on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. Finally, JPMorgan Chase & Co. increased their price objective on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a report on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $90.31.

Insider Transactions at Cooper Companies

In related news, Director Lawrence Erik Kurzius acquired 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The stock was purchased at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the purchase, the director directly owned 7,777 shares of the company’s stock, valued at $641,602.50. This trade represents a 34.62% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Holly R. Sheffield bought 1,230 shares of the company’s stock in a transaction on Tuesday, December 16th. The shares were bought at an average cost of $80.75 per share, for a total transaction of $99,322.50. Following the transaction, the insider owned 39,052 shares in the company, valued at $3,153,449. The trade was a 3.25% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders have bought 16,014 shares of company stock worth $1,304,416. Insiders own 1.98% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

Several institutional investors have recently added to or reduced their stakes in COO. Vanguard Group Inc. increased its stake in Cooper Companies by 1.8% during the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock worth $1,725,963,000 after acquiring an additional 421,423 shares during the last quarter. Capital World Investors increased its position in shares of Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after acquiring an additional 2,159,233 shares during the period. State Street Corp raised its position in Cooper Companies by 1.2% during the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after purchasing an additional 104,910 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Cooper Companies by 2.5% during the 2nd quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company’s stock valued at $368,893,000 after purchasing an additional 127,907 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.